Clinical Trial Update: NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating NovoTTF-200A (Optune) with temozolomide chemoradiation for newly diagnosed glioblastoma. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• NovoTTF-200A (Optune)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Hackensack Meridian Health | Conditions: Glioblastoma, Adult | Phase 1 | Status: COMPLETED